Could this cocktail slow ALS? new trial launches
NCT ID NCT07414212
First seen Feb 19, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This study tests whether adding two supplements (NAC and EH-301) to standard ALS medication (riluzole) can slow down the disease or improve symptoms. About 90 people with early-stage ALS will receive either the active combination or a placebo for 6 months, followed by an optional 6-month open-label phase where everyone gets the active treatment. The goal is to see if the combination helps maintain daily function and muscle strength.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario Donostia
RECRUITINGSan Sebastián, Guipuzcoa, 20003, Spain
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.